S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
How major US stock indexes fared Thursday, 4/11/2024
Closing prices for crude oil, gold and other commodities
Carmax Returns to the Bargain Basement: Buy the Dip? 
Homebuyers’ quandary: to wait or not to wait for lower mortgage rates
S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
How major US stock indexes fared Thursday, 4/11/2024
Closing prices for crude oil, gold and other commodities
Carmax Returns to the Bargain Basement: Buy the Dip? 
Homebuyers’ quandary: to wait or not to wait for lower mortgage rates
S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
How major US stock indexes fared Thursday, 4/11/2024
Closing prices for crude oil, gold and other commodities
Carmax Returns to the Bargain Basement: Buy the Dip? 
Homebuyers’ quandary: to wait or not to wait for lower mortgage rates
S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
How major US stock indexes fared Thursday, 4/11/2024
Closing prices for crude oil, gold and other commodities
Carmax Returns to the Bargain Basement: Buy the Dip? 
Homebuyers’ quandary: to wait or not to wait for lower mortgage rates
LON:IMM

ImmuPharma (IMM) Share Price, News & Analysis

GBX 2.44
-0.01 (-0.53%)
(As of 07:57 AM ET)
Today's Range
2.35
2.58
50-Day Range
0.85
2.57
52-Week Range
0.82
3.80
Volume
679,495 shs
Average Volume
2.64 million shs
Market Capitalization
£10.15 million
P/E Ratio
N/A
Dividend Yield
0.77%
Price Target
N/A
IMM stock logo

About ImmuPharma Stock (LON:IMM)

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candidates include BioAMB, a peptide-based drug for the treatment of Amphotericin-B formulations, a fungal infection caused by the aspergillus family of fungi; and BioCin, a peptide-based antibacterial drug used in high medical need cases and in last line of defense. The company has a collaboration arrangement with Centre National de la Recherche Scientifique for the development of a peptide technology platform for treating diabetes with glucagon-like peptide -1 agonists, as well as development of peptides as glucagon antagonists to treat type I and type II diabetes; and license and development agreement with Avion Pharmaceuticals LLC. ImmuPharma plc was founded in 1999 and is headquartered in London, the United Kingdom.

IMM Stock Price History

IMM Stock News Headlines

Bidencare Comes For Your 401(k) – How To Optout
First Obamacare For Health, Now Bidencare For 401(k)s - How To Optout
ImmuPharma PLC IMM
Bidencare Comes For Your 401(k) – How To Optout
First Obamacare For Health, Now Bidencare For 401(k)s - How To Optout
ImmuPharma PLC (25I.SG)
ImmuPharma shares jump 6.5% after FDA update
ImmuPharama eyes clinical trial progress
ImmuPharma eyes clinical trial progress
ImmuPharma "looking forward" to upcoming FDA meetings
ImmuPharma partner gets FDA meeting date
See More Headlines
Receive IMM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ImmuPharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/30/2020
Today
4/12/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

Net Income
£-2,990,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£94,819.00
Cash Flow
GBX 0.12 per share

Miscellaneous

Free Float
N/A
Market Cap
£10.15 million
Optionable
Not Optionable
Beta
1.32
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Timothy Paul McCarthy XIV (Age 68)
    FCCA, M.B.A., MBA, Chairman & CEO
    Comp: $106.5k
  • Dr. Timothy Gary Franklin M.B.A. (Age 60)
    Ph.D., COO & Director
    Comp: $92.5k
  • Ms. Lisa Baderoon (Age 58)
    Head of Investor Relations & Non Executive Director
    Comp: $48k
  • Dr. Jean-Marie Geiger PharmD
    MD, Head of Clinical Development
  • Dr. Laura Mauran-Ambrosino
    Chief Scientific Officer of ImmuPharma Biotech
  • Ms. Lara E. Sucheston-Campbell
    Head of Clinical & Medical Affairs
  • Dr. Sébastien R. Goudreau Ph.D. (Age 43)
    CEO of ImmuPharma Biotec & Director

IMM Stock Analysis - Frequently Asked Questions

How have IMM shares performed in 2024?

ImmuPharma's stock was trading at GBX 1.67 at the beginning of the year. Since then, IMM shares have increased by 46.1% and is now trading at GBX 2.44.
View the best growth stocks for 2024 here
.

How were ImmuPharma's earnings last quarter?

ImmuPharma plc (LON:IMM) issued its earnings results on Wednesday, September, 30th. The company reported ($1.69) earnings per share for the quarter.

What other stocks do shareholders of ImmuPharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ImmuPharma investors own include Castleton Technology (CTP), MOTIF BIO PLC/S (MTFB), Aminex (AEX), Legendary Investments (LEG), Richland Resources Ltd (RLD.L) (RLD), Sound Energy (SOU), Thor Energy (THR), Acacia Mining (ACA), ALU (ALU) and (DARA) (DARA).

How do I buy shares of ImmuPharma?

Shares of IMM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:IMM) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners